California AB1887 mandates health insurers to approve prior authorization for FDA-approved rare disease drugs within 30 days.

California AB1887 requires health insurers to approve prior authorization for FDA-approved drugs treating rare diseases within 30 days if prescribed by a specialist. A rare disease is defined as one affecting fewer than 200,000 people in the United States. The bill applies to health insurance policies and health care service plans issued, amended, or renewed on or after January 1, 2027.

California AB1887 mandates health insurers to approve prior authorization for FDA-approved rare disease drugs within 30 days.

California AB1887 requires health insurers to approve prior authorization for FDA-approved drugs treating rare diseases within 30 days if prescribed by a specialist. A rare disease is defined as one affecting fewer than 200,000 people in the United States. The bill applies to health insurance policies and health care service plans issued, amended, or renewed on or after January 1, 2027.